She described him as unresponsive to voice, stiff body with rhythmic shaking of his arms and legs.
In the ED he was loaded with dilantin and given zofran.
Past Medical History: - pituitary tumor (benign) s/p resection at [**Hospital1 2025**] in the [**2124**]'s and treated with radiation - R temporal cavernoma seen on prior MRI's and with prior bleeding (pt is unaware of this) - panhypopituitary - basal cell CA - lipoma  Social History: -married with 5 children, works as a guidance counselor -denied EtOH, tobacco or drugs   Family History:  multiple members with alcoholism -father: heart and lung problems -mother: gallbladder and kidney stones -no history of strokes, seizures or abnormal blood vessels   Physical Exam: Vitals: T: 96.7 P: 56 R: 20 BP: 143/108 -> 110/76 SaO2: 99% RA General: Awake, cooperative, NAD.
Pertinent Results: Admission Labs:  [**2152-8-31**] 11:15AM   PLT COUNT-234 [**2152-8-31**] 11:15AM   NEUTS-61.1 LYMPHS-34.3 MONOS-3.0 EOS-0.7 BASOS-1.0 [**2152-8-31**] 11:15AM   WBC-11.0 RBC-5.27 HGB-16.5 HCT-48.8 MCV-93 MCH-31.4 MCHC-33.9 RDW-13.5 [**2152-8-31**] 11:15AM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2152-8-31**] 11:15AM   TOT PROT-6.9 [**2152-8-31**] 11:15AM   cTropnT-<0.01 [**2152-8-31**] 11:15AM   ALT(SGPT)-24 AST(SGOT)-29 CK(CPK)-78 ALK PHOS-45 [**2152-8-31**] 11:15AM   GLUCOSE-96 UREA N-21* CREAT-1.1 [**2152-8-31**] 11:21AM   GLUCOSE-88 LACTATE-6.1* NA+-141 K+-3.7 CL--105 TCO2-17* [**2152-8-31**] 12:15PM   PT-13.5* PTT-25.7 INR(PT)-1.2* [**2152-8-31**] 02:45PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 LEUK-NEG [**2152-8-31**] 02:45PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.011 [**2152-8-31**] 07:04PM   CALCIUM-8.2* PHOSPHATE-1.9* MAGNESIUM-2.0 .
He was initially started on Dilantin for seizure prophylaxis.
There he was changed from Dilantin to Keppra for long-term seizure prophylaxis, for easier up-titration and less drug interactions with his hormone replacement medications.
He tolerated the Keppra well, and was discharged with a titration schedule up to 1000 mg [**Hospital1 **].
He was asked to follow up with Dr. [**First Name (STitle) **] with Neuro-Surgery to discuss treatment options for the cavernoma (including surgery, Cyberknife, or observation), and with Dr. [**First Name (STitle) **] in our stroke service.
Medications on Admission: - prednisone 5mg PO QD - synthroid 125 mcg PO QD - ASA 81 mg PO QD - MVI - androgen topical  Discharge Medications: 1.
Prednisone 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Levothyroxine 50 mcg Tablet Sig: 2.5 Tablets PO DAILY (Daily).
Keppra 500 mg Tablet Sig: Two (2) Tablet PO twice a day: 1 tab twice daily until [**9-6**], then 1.5 tabs twice daily until [**9-9**], then 2 tabs twice daily.
Famotidine 20 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
You were started on a new medication, Keppra (500 mg tabs) to prevent seizures.
We have stopped your aspirin to reduce the risk of further bleeding.
